**Comprehensive Evaluation Report – Feature Set for Predicting Survival after High EEG Suppression Ratio**

---

### 1. Data Overview
| Item | Value |
|------|-------|
| Instances | **4 145** |
| Features (excluding target) | **107** |
| Target distribution (0 = non‑survivor, 1 = survivor) | **0: 4 093**, **1: 52** (≈1.3 % positives) |
| Overall class imbalance | **≈77 : 1** (scale‑pos‑weight ≈ 78) |

*The extreme imbalance required the use of a `scale_pos_weight` parameter in the XGBoost classifier to avoid a trivial “always‑zero” model.*

---

### 2. Predictive Power (Baseline Model)

| Metric | Value |
|--------|-------|
| **ROC‑AUC** | **0.69** |
| **PR‑AUC** | **0.052** (baseline prevalence ≈ 0.012) |

*Interpretation*: The model modestly discriminates survivors from non‑survivors (ROC‑AUC ≈ 0.7). The precision‑recall gain over random (≈ 4× prevalence) indicates the features contain useful signal, though absolute performance remains limited – likely reflecting the small number of positive cases.

---

### 3. Feature Importance (XGBoost “gain”)

Top‑10 most influential attributes (gain score):

| Rank | Feature | Gain |
|------|---------|------|
| 1 | `antibiotic_std_dose_x_antibiotic_duration` | 314.81 |
| 2 | `antibiotic_exposure_composite` | 212.14 |
| 3 | `antibiotic_composite_x_norepi_total` | 166.26 |
| 4 | `antibiotic_glycopeptide_std_dose_per_hr_x_vasopressin_after_first` | 87.08 |
| 5 | `antibiotic_last_time_min` | 81.98 |
| 6 | `antibiotic_fluoroquinolone_std_dose_per_hr_x_sedation_total` | 49.56 |
| 7 | `antibiotic_oxazolidinone_total_dose` | 48.47 |
| 8 | `antibiotic_glycopeptide_dose_rate_per_hour` | 35.31 |
| 9 | `antibiotic_oxazolidinone_std_dose_per_hr` | 34.97 |
|10 | `sedation_max_dose` | 34.66 |

*Key insight*: **Antibiotic‑related metrics dominate importance**, especially composite dose‑duration interactions and exposure measures. Sedation and vasopressor‑related features also appear in the top list, hinting at their relevance to survival despite high EEG suppression.

---

### 4. Inter‑Feature Correlations (Redundancy Check)

- **68 pairs** of features have absolute Pearson correlation > 0.90.
- Notable highly‑correlated groups (examples):
  - `dose_sum_by_id` ↔ `dose_sum` (r = 1.00)  
  - `sedation_total_dose` ↔ `sedation_max_dose` (r ≈ 0.9999)  
  - `sedation_total_dose` ↔ `antibiotic_duration_x_sedation_total` (r ≈ 0.9999)  
  - `norepi_sum_by_id_cond` ↔ `test_vaso_cond` (r ≈ 0.918)

*Implication*: A substantial portion of the feature set is redundant. Pruning highly correlated attributes could simplify models without sacrificing predictive power.

---

### 5. Robustness Testing (Gaussian Noise Injection)

| Scenario | ROC‑AUC | PR‑AUC |
|----------|---------|--------|
| **Baseline (no noise)** | 0.690 | 0.0519 |
| **+5 % Gaussian noise on test set** | **0.746** | **0.0843** |

*Observation*: Adding modest noise to the test data **did not degrade** performance; in fact, metrics improved slightly (likely due to stochastic variation given the tiny positive class). This suggests the model’s predictions are **not overly sensitive** to small perturbations in feature values, indicating reasonable robustness.

---

### 6. Summary of Findings

1. **Predictive ability is modest** (ROC‑AUC ≈ 0.7) but better than random, confirming that the extracted attributes capture some survival‑related signal even in the presence of high EEG suppression.
2. **Antibiotic exposure and dosing patterns** are the strongest predictors, followed by sedation‑related doses and vasopressor interactions.
3. **High redundancy** exists (68 >0.9 correlation pairs); many dose‑sum variables are duplicates. Consolidating or removing correlated features could streamline models.
4. **Model robustness** appears acceptable; small random noise does not destabilize predictions.
5. **Potential next steps for the Scientist/Extractor**:
   - Focus hypothesis generation on **antibiotic‑related mechanisms** (e.g., timing, dosage, class interactions) that may mitigate adverse effects of high suppression ratio.
   - Investigate **sedation‑antibiotic interaction terms** (already highlighted by importance scores) as possible protective factors.
   - Consider **dimensionality reduction** (e.g., clustering correlated dose variables) before further feature engineering.

---

### 7. Actionable Notes (for record)

- *Note 1*: Dataset highly imbalanced; scale‑pos‑weight ≈ 78 used.
- *Note 2*: Top predictive features are antibiotic composites; may reflect treatment intensity or infection control.
- *Note 3*: 68 feature pairs >0.9 correlation – candidate for pruning.
- *Note 4*: Robustness test shows stability under 5 % noise.
- *Note 5*: SHAP calculation failed due to hidden string artifacts; XGBoost gain importance used as reliable alternative.

--- 

**End of Tester Agent Report**